The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
The objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022
Srichakra receives European Food Safety approval for its food-grade recycled rPET
Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered
Go-ahead for pivotal clinical trial which is expected to commence by March
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
Subscribe To Our Newsletter & Stay Updated
